Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05794295 · ClinicalTrials.gov registry record · NA
Sleep Architecture & Cognition in Focal Epilepsy
A NA study of Focal Epilepsy, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05794295: Recruiting NA study of Focal Epilepsy, sponsored by University of California, Davis.
NCT05794295 is a NA study of Focal Epilepsy that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 40 participants, below the 167-participant average among 8 other Focal Epilepsy trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05794295, a NA study of Focal Epilepsy, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Focal Epilepsy (FE) patients and healthy controls will wear an actigraph at home for one week and a home sleep study device at home for one night. Participants will then undergo two nights of testing (at least one week apart) at California Sleep Solutions (CSS) in Sacramento, CA. During the overnight stays, participants will have EEG leads placed and possibly a headband. They will undergo cognitive testing before they go to sleep and again in the morning. During one night of testing, sounds will be played in the room (acoustic stimulation). The sounds should not wake the participants.
Primary Outcome
Alertness Test; charts how alert a participant feels for up to 18 hours of the day for 7 days; scale is from 1-7 with higher scores meaning more sleepiness; abnormal is 4 and above
Conditions Studied
Interventions
- OTHER Acoustic Stimulation (AS)
- OTHER SHAM Stimulation
Study Locations (1)
California
- UC Davis - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-01-24 |
| Est. Completion | 2028-06 |
| Phase | NA |
What NCT05794295 shows while recruiting
NCT05794295 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 167-participant average among 8 other Focal Epilepsy trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Focal Epilepsy appearing as the primary indexed condition, and to 2 interventions - of which Acoustic Stimulation (AS) is the first listed.
NCT05794295 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05794295 about?
NCT05794295 is a clinical study titled "Sleep Architecture & Cognition in Focal Epilepsy". Focal Epilepsy (FE) patients and healthy controls will wear an actigraph at home for one week and a home sleep study device at home for one night. Participants will then undergo two nights of testing (at least one week apart) at California Sleep Solutions (CSS) in Sacramento, CA. During the overnigh...
What is the current status of trial NCT05794295?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-01-24. Estimated completion is 2028-06.
What conditions does trial NCT05794295 study?
This clinical trial studies the following conditions: Focal Epilepsy.
What interventions are being tested in trial NCT05794295?
The interventions under investigation include: Acoustic Stimulation (AS) (OTHER), SHAM Stimulation (OTHER).
Who is sponsoring clinical trial NCT05794295?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05794295 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Focal Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05794295's enrollment target sits among peer trials
40 6th of 8 higher than 3 of 8 other Focal Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Focal Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Diffusion MRI Methods to Minimize Postoperative Deficits in Pediatric Epilepsy Surgery
RECRUITING · NA
-
Breathing Rescue for SUDEP Prevention
RECRUITING · NA
-
Study of Transcranial Direct Current Stimulation to Treat Epilepsy
RECRUITING · NA
-
Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
RECRUITING · NA
-
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
RECRUITING · Phase 2
-
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI